CAMBODGE NOM. And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) – CAMBODGE NOM. (CBDG.PA), GJENSIDIGE FORSIKR (GJF.OL), WERELDHAVE BELGIUM (WEHB.BR) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. CAMBODGE NOM. (CBDG.PA)

1565.22% Payout Ratio

Compagnie du Cambodge, together with its subsidiaries, provides transportation and logistics services in France. It operates a railway concession linking Burkina Faso with Ivory Coast. The company was incorporated in 1998 and is headquartered in Puteaux, France. Compagnie du Cambodge is a subsidiary of Plantations Des Terres Rouges S.A.

Earnings Per Share

As for profitability, CAMBODGE NOM. has a trailing twelve months EPS of €11.64.

PE Ratio

CAMBODGE NOM. has a trailing twelve months price to earnings ratio of 579.9. Meaning, the purchaser of the share is investing €579.9 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.17%.

Volume

Today’s last reported volume for CAMBODGE NOM. is 2 which is 100% above its average volume of 1.

More news about CAMBODGE NOM..

2. GJENSIDIGE FORSIKR (GJF.OL)

87.67% Payout Ratio

Gjensidige Forsikring ASA provides general insurance and pension products in Norway, Sweden, Denmark, Latvia, Lithuania, and Estonia. The company operates through six segments: General Insurance Private, General Insurance Commercial, General Insurance Denmark, General Insurance Sweden, General Insurance Baltics, and Pension. It offers motor, accident and health, travel, leisure craft, valuables, liability, commercial, marine/transport, agriculture, natural perils, life, and pet insurance products. The company also provides defined contribution occupational pension schemes for businesses, which include disability pension, spouse/cohabitant pension, and child's pension products. It distributes its products through various distribution channels comprising office channel, call center, Internet, partners, and brokers to private and commercial customers. The company was founded in 1816 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, GJENSIDIGE FORSIKR has a trailing twelve months EPS of kr9.42.

PE Ratio

GJENSIDIGE FORSIKR has a trailing twelve months price to earnings ratio of 19.31. Meaning, the purchaser of the share is investing kr19.31 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.65%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

GJENSIDIGE FORSIKR’s EBITDA is 2.63.

More news about GJENSIDIGE FORSIKR.

3. WERELDHAVE BELGIUM (WEHB.BR)

65.5% Payout Ratio

Wereldhave Belgium is a public regulated real estate company with a focus on commercial property in Belgium. Wereldhave Belgium targets its new investments on shopping centres. The value of the real estate portfolio, including project developments, amounted to € 921.2 mln on 31 December 2020. On 31 December 2020 the existing operational retail portfolio amounted to € 817.8 mln (around 90% of the total portfolio) and it includes shopping centres in Liège, Nivelles, Tournai, Genk and Kortrijk and retail parks in Brugge, Ghent, Turnhout, Waterloo and Tournai. In addition, the portfolio of real estate investments includes offices in Vilvoorde and Antwerp. As of 31 December 2020 the development portfolio of € 12.6 mln contained land holdings and realised investments that relate to the refurbishment and/or expansion of shopping centres in Waterloo and Liège.

Earnings Per Share

As for profitability, WERELDHAVE BELGIUM has a trailing twelve months EPS of €6.25.

PE Ratio

WERELDHAVE BELGIUM has a trailing twelve months price to earnings ratio of 7.71. Meaning, the purchaser of the share is investing €7.71 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.05%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Apr 17, 2023, the estimated forward annual dividend rate is 4.2 and the estimated forward annual dividend yield is 8.61%.

Volume

Today’s last reported volume for WERELDHAVE BELGIUM is 2112 which is 13.91% above its average volume of 1854.

More news about WERELDHAVE BELGIUM.

4. EQUASENS (EQS.PA)

37.7% Payout Ratio

Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

Earnings Per Share

As for profitability, EQUASENS has a trailing twelve months EPS of €2.96.

PE Ratio

EQUASENS has a trailing twelve months price to earnings ratio of 26.96. Meaning, the purchaser of the share is investing €26.96 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.59%.

Volume

Today’s last reported volume for EQUASENS is 2527 which is 38.01% below its average volume of 4077.

Moving Average

EQUASENS’s worth is higher than its 50-day moving average of €73.71 and above its 200-day moving average of €74.79.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 202.74M for the twelve trailing months.

Sales Growth

EQUASENS’s sales growth for the current quarter is 7%.

More news about EQUASENS.

Leave a Reply

Your email address will not be published. Required fields are marked *